Erschienen in:
10.05.2019 | Review Article
Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials
verfasst von:
Philip Zeitler
Erschienen in:
World Journal of Pediatrics
|
Ausgabe 4/2019
Einloggen, um Zugang zu erhalten
Abstract
Background
Due to the dramatic increase in the rates of childhood obesity and youth-onset type 2 diabetes (T2D) in the late 1990s in the United States, the US government, through the National Institute of Diabetes, Digestive Disease, and Kidney (NIDDK) and the Centers for Disease Control, funded a series of large studies and trials which, together, have formed the basis for much of what we currently understand about youth-onset T2D.
Data sources
The review focus on the recent results and implications of the treatment options for Type 2 Diabetes in Adolescents and Youth (TODAY) study and the Restoring Insulin Secretion (RISE) study.
Results and Conclusions
Both TODAY and RISE studies have provided critical insight into the unique aspects of the pathophysiology of youth-onset type 2 diabetes and also provided the evidence base for our current approach to the management of this disorder.